Wyoming pharmaceutical company Cody Laboratories will shut down operations in September, resulting in about 80 employees losing their jobs, according to The Powell Tribune.
Pharmacy
Civica Rx, the hospital-owned generic drug company, is collaborating with Vizient to help reduce drug shortages.
Pfizer plans to acquire Array BioPharma in a deal valued at $11.4 billion, the companies announced June 17.
Lupin Pharmaceuticals is recalling 18,408 bottles of an antibiotic from the U.S. market.
Three major U.S. drugmakers have sued HHS in an attempt to block a rule that would require them to disclose the list price of prescription drugs in their television advertisements, according to Bloomberg.
Bluebird Bio has priced Zynteglo, its gene therapy for a blood disorder, at $1.8 million, according to STAT news.
The owner of a pain clinic and pharmacy in Florida was sentenced to more than six years in prison and three years probation for his role in a $2.2 million insurance fraud scheme, according to the U.S. Justice Department.
Ten hospitals and health systems that posted job listings seeking pharmacy leaders in the last week:
A federal appeals court revived a class-action lawsuit alleging CVS Health overcharged millions of customers for generic drugs, according to the San Francisco Chronicle.
Four drugs or medical devices approved by the FDA since June 7: